| Product Code: ETC7538783 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India bronchopulmonary dysplasia market import shipment experienced a significant decline with a CAGR of -26.9% from 2020 to 2024. The growth rate between 2023 and 2024 plummeted by 50.0%, indicating a sharp contraction. The market exhibited a notable trend of contraction and deceleration during this period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Bronchopulmonary Dysplasia Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Bronchopulmonary Dysplasia Market Revenues & Volume, 2021 & 2031F |
3.3 India Bronchopulmonary Dysplasia Market - Industry Life Cycle |
3.4 India Bronchopulmonary Dysplasia Market - Porter's Five Forces |
3.5 India Bronchopulmonary Dysplasia Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 India Bronchopulmonary Dysplasia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bronchopulmonary dysplasia in infants in India |
4.2.2 Growing awareness and diagnosis of respiratory conditions in infants |
4.2.3 Technological advancements in respiratory care for premature infants |
4.3 Market Restraints |
4.3.1 Lack of specialized healthcare facilities for neonatal care in certain regions of India |
4.3.2 High cost associated with treatment and management of bronchopulmonary dysplasia |
4.3.3 Limited access to advanced medical equipment and therapies in some healthcare settings |
5 India Bronchopulmonary Dysplasia Market Trends |
6 India Bronchopulmonary Dysplasia Market, By Types |
6.1 India Bronchopulmonary Dysplasia Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 India Bronchopulmonary Dysplasia Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 India Bronchopulmonary Dysplasia Market Revenues & Volume, By Pneumostem, 2021- 2031F |
6.1.4 India Bronchopulmonary Dysplasia Market Revenues & Volume, By UMC 119 01, 2021- 2031F |
6.1.5 India Bronchopulmonary Dysplasia Market Revenues & Volume, By AT 100, 2021- 2031F |
6.1.6 India Bronchopulmonary Dysplasia Market Revenues & Volume, By OHB-607, 2021- 2031F |
7 India Bronchopulmonary Dysplasia Market Import-Export Trade Statistics |
7.1 India Bronchopulmonary Dysplasia Market Export to Major Countries |
7.2 India Bronchopulmonary Dysplasia Market Imports from Major Countries |
8 India Bronchopulmonary Dysplasia Market Key Performance Indicators |
8.1 Average length of hospital stay for infants with bronchopulmonary dysplasia |
8.2 Rate of adoption of new respiratory care technologies in neonatal units |
8.3 Percentage of healthcare providers trained in bronchopulmonary dysplasia management |
9 India Bronchopulmonary Dysplasia Market - Opportunity Assessment |
9.1 India Bronchopulmonary Dysplasia Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 India Bronchopulmonary Dysplasia Market - Competitive Landscape |
10.1 India Bronchopulmonary Dysplasia Market Revenue Share, By Companies, 2024 |
10.2 India Bronchopulmonary Dysplasia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |